Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

107.95

-2.74 (-2.48%)

At close: Aug 6, 2026, 4:00 PM EDT

108.06

+0.11 (0.10%)

Pre-market: Aug 7, 2026, 8:05 AM EDT

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	11,669	3,688	5,297	3,359	2,190	2,098
Market Cap Growth	54.30%	-30.38%	57.70%	53.35%	4.41%	-31.31%
Enterprise Value	11,134	3,322	4,920	2,991	1,760	1,875
Last Close Price	107.95	34.80	50.39	32.48	20.31	19.80

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	237.96	42.44	40.97	34.55	23.34	22.25
Forward PE	27.31	55.53	32.11	32.61	19.95	21.01
PEG Ratio	-	1.96	1.96	1.96	1.96	1.50
PS Ratio	14.05	4.84	7.85	6.96	5.45	5.73
PB Ratio	16.51	5.69	7.79	6.63	4.36	5.58
P/TBV Ratio	17.67	6.45	8.41	7.16	4.69	6.64
P/FCF Ratio	109.14	26.01	27.01	26.54	18.26	12.53
P/OCF Ratio	106.37	25.97	26.71	26.51	18.20	12.49

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	13.40	4.36	7.29	6.20	4.38	5.12
EV/EBITDA Ratio	1318.57	72.29	35.72	27.61	15.45	14.88
EV/EBIT Ratio	1738.33	74.15	35.93	27.88	15.62	15.06
EV/FCF Ratio	104.13	23.43	25.09	23.63	14.67	11.20

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0	0	0
Debt / EBITDA Ratio	1.12	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.09	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.42	-0.56	-0.55	-0.73	-0.86	-0.59
Net Debt / EBITDA Ratio	-35.38	-7.97	-2.73	-3.40	-3.78	-1.77
Net Debt / FCF Ratio	-2.79	-2.58	-1.92	-2.91	-3.59	-1.33
Asset Turnover	0.96	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.08	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.50	2.60	3.11	4.05	6.58	5.28
Current Ratio	2.86	2.92	3.35	4.39	6.89	5.60
Return on Equity (ROE)	8.15%	15.01%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	1.55%	8.01%	16.38%	15.17%	19.52%	22.51%
Return on Invested Capital (ROIC)	3.74%	22.96%	54.21%	87.09%	87.74%	94.15%
Return on Capital Employed (ROCE)	0.91%	6.54%	22.51%	20.87%	25.39%	27.65%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.47%	2.36%	2.44%	2.89%	4.28%	4.49%
FCF Yield	0.92%	3.84%	3.70%	3.77%	5.48%	7.98%
Buyback Yield / Dilution	0.22%	-5.73%	-1.56%	3.64%	7.94%	-1.42%
Total Shareholder Return	0.22%	-5.73%	-1.56%	3.64%	7.94%	-1.42%

SEC Filings: 10-K · 10-Q